As of Tuesday, January 13, Travere Therapeutics, Inc.’s TVTX share price has dipped by 27.74%, which has investors ...

Travere Therapeutics Stock (TVTX) is plummeting on news of a potential FDA delay for its kidney disease treatment ...

Alphabet rose 1.8%. The Google parent’s class A shares added 1% on Monday, closing at a record high of $331.86. The gains ...

Shares of Travere Therapeutics (NASDAQ:TVTX) plunged around 33% on Tuesday after the company disclosed that U.S. regulators ...

Investing.com -- Travere Therapeutics (NASDAQ:TVTX) stock tumbled 33% Tuesday after the company revealed that the U.S. Food ...

Intel (NASDAQ:INTC) stock gained 3.6% and Advanced Micro Devices (NASDAQ:AMD) rose 2.6% after KeyBanc upgraded both the ...

Lulu’s Fashion Lounge Holdings Inc (NASDAQ: LVLU) shares dipped 10.4% to $10.89 in pre-market trading. Lulu’s Fashion Lounge ...

Shares of Heritage Global Inc (NASDAQ: HGBL) rose sharply in pre-market trading after the company announced its subsidiary, Heritage DebtX, acquired substantially all of the assets of The Debt ...

Detailed price information for Travere Therapeutics Inc (TVTX-Q) from The Globe and Mail including charting and trades.

Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that, based on preliminary and unaudited financial data, the Company expects total U.S. net product sales for the fourth quarter of 2025 to be ...

Dr Suneel Udani recounts a young mother’s experience with new therapies that lowered proteinuria, stabilized/improved kidney ...

Dr Suneel Udani unfolds how one patient’s struggle with deteriorating IgA nephropathy now inspires hope as new therapies ...